Comparative Effectiveness of Oxiris Hemofilters Versus Conventional Hemofilters in Septic Patients
December 26, 2024 updated by: Bakirkoy Dr. Sadi Konuk Research and Training Hospital
Comparative Effectiveness of Oxiris Filters Versus Conventional Hemofilters in Septic Patients: a Retrospective Cohort Study
We divided patients in 2 groups. First group was the patients who received Oxiris filters during CRRT. Second group was the patiens who have received CRRT filters other than Oxiris.
We compared the lab parameters (Urea, Creatinin, Lactate, ABG parameters and SOFA escore with together.
Study Overview
Status
Completed
Intervention / Treatment
Study Type
Observational
Enrollment (Actual)
426
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Istanbul, Turkey
- Bakirkoy Dr Sadi Konuk Research and Training Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
study population includes patients who have admission on our clinic for more than 5 days and diagnosed with sepsis who has CRRT indication
Description
Inclusion Criteria:
sepsis diagnosis CRRT indication
Exclusion Criteria:
patients under age of 18
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Oxiris
The group which we used oxiris filter for CRRT.
|
Hemodiafiltration
|
|
Non-Oxiris
The group which we used other filters like M150 for CRRT.
|
Hemodiafiltration
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
SOFA Score
Time Frame: 6 month
|
We compared SOFA scores of patients on admission and on 5th day.
|
6 month
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Survival comparison
Time Frame: 6 month
|
We compared patients survival rates between two group.
|
6 month
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 23, 2024
Primary Completion (Actual)
November 1, 2024
Study Completion (Actual)
December 1, 2024
Study Registration Dates
First Submitted
December 11, 2024
First Submitted That Met QC Criteria
December 11, 2024
First Posted (Actual)
March 25, 2025
Study Record Updates
Last Update Posted (Actual)
March 25, 2025
Last Update Submitted That Met QC Criteria
December 26, 2024
Last Verified
December 1, 2024
More Information
Terms related to this study
Other Study ID Numbers
- 2024-05-02
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.